series A

Aiolos Bio raises $250M for severe asthma drug

Aiolos Bio debuts with $250M and ex-Gyroscope CEO to tackle severe asthma

Anika Sharma

A striking trend throughout 2023 has been the gravitational pull of significant funding toward promising biotech endeavors. This theme is ...

Precede Biosciences raises $57M to advance liquid biopsy platform

Precede Biosciences raises $57M to advance liquid biopsy platform

Anika Sharma

A promising new venture, emerging from the esteemed Dana-Farber Cancer Institute, is set to revolutionize the landscape of cancer diagnostics ...